Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

China Resources Double-Crane Pharmaceutical Co Ltd Divests Stake in Subsidiary


Thursday, 10 Oct 2013 08:00pm EDT 

China Resources Double-Crane Pharmaceutical Co Ltd announced that it has completed the divestiture of holdings in a subsidiary, Changsha Double-Crane Medicine Co., Ltd. on October 10, 2013. The plan was disclosed on May 11, 2013. 

Company Quote